Do psychedelics reduce distress for palliative care patients? EU funds study to find out
European researchers have started work on a clinical trial of psychedelics in palliative care patients. The study will investigate whether psilocybin, a compound found in magic mushrooms (or shrooms), is safe and effective in relieving psychological distress for people suffering from one of four advanced illnesses. It’s the first time the EU has funded a study into psychedelic-assisted therapy. According to the Dutch University Medical Centre Groningen (UMCG), which is coordinating the trial, the European bloc has allocated more than €6.5 million to the project, called PsyPal. Clinics in the N...